The Heart of Cannabis Profits

Written by Jimmy Mengel
Posted February 14, 2019

In honor of Valentine's Day, when lovers all over the world are pledging to give one another their hearts, I wanted to spend some time discussing the heart.

Not in that intangible, loving sense, but literally giving someone your heart...

In December of 1967, South African surgeon Christiaan Barnard made medical history when he inserted the heart of a dead man into the living body of another.

It was the world's first successful heart transplant, yet much of the public was still split between whether Barnard was a genius or a madman.

Even his patient, Louis Washkansky, declared himself to be the “new Frankenstein.”

You see, organ transplants were very controversial at the time. Some religious groups condemned the practice as “playing god.” Others shunned it for desecrating the human body. Many folks were paranoid that we would start allowing healthy people to die in order to harvest their organs for wealthier citizens.

But today, organ transplants are well-recognized as one of medicine's crowning achievements. Now almost nobody bats an eye when we talk about saving lives through organ transplantation. We even have to decide whether or not to donate our own organs just to get a driver's license.

Thousands of lives have been saved by these procedures...

One study showed that organ transplants have saved more than 2 million years of life in the United States in the last 25 years alone...

The point is, that which was once considered taboo has now been roundly accepted as a medical miracle.

There is another taboo about to be broken in the medical field, and one of the biggest possibilities revolves around a natural way to repair the heart.

It could potentially cut down the need for heart transplants overall, and make investors very wealthy in the process...

Heart disease currently kills more people per year than any other cause. Roughly 5.7 million adults suffered from it in the United States alone, as of 2016. It’s practically a death sentence.

Half of the victims will die within five years of their diagnosis.

It kills 610,000 Americans every single year. That’s one in every four deaths

It also weighs heavily on the medical and insurance systems: its cost to the U.S. economy is a staggering $30.7 billion per year.

Globally, this is a $93 billion problem.

Despite the huge amount of money being spent on treatment, innovation on new treatments has been tragically slow...

For example, diastolic heart failure — a major cause of premature death, hasn’t had an effective, new therapy in over 20 years.

One tiny biotech company believes that a breakthrough in medical cannabis could be the answer that people suffering from heart disease have been praying for...

Now, scientists are already extracting cannabidiol (CBD) from cannabis to create new therapies for Alzheimer’s, arthritis, diabetes, chronic pain, epilepsy, autoimmune disease, and even cancer.

That enormous potential is why the global medical marijuana market is projected to reach a value of USD $55.8 billion by 2025, according to Grand View Research.

It’s also why companies like GW Pharma, INSYS, Zynerba, and others have achieved market valuations ranging from $300 million to over $3 billion.

Heart disease, however, has been largely ignored. That's a shame considering the potential CBD has shown in early studies...

From one study:

The root cause of heart failure is inflammation in the tissues of the heart. The muscles swell up, stiffen, and fail to pump enough oxygen-rich blood to support your body.

If you can reverse the inflammation, you can heal the heart.

That’s what the science shows CBD can do.

It flushes out inflammation in diabetic cardiomyopathy. It prevents tissues from stiffening up in autoimmune myocarditis. It dramatically reduces cardiac ischemia.

If you’re not a doctor — that’s a bit of a mouthful. The bottom line is this: CBD can reverse all the major signs and symptoms of heart disease.

The tiny company I've discovered has developed a breakthrough treatment with the University of Alberta over the past eight years at a cost of more than $3.5 million in R&D expenditures.

The scientists who invented it are part of an in-house team of world-leading cardiologists, immunologists, oncologists, and recognized authorities on drug delivery.

They have also teamed up with the Cleveland Clinic, which was rated the #1 U.S. hospital for adult cardiology & heart surgery by U.S. News and World Report.

The hospital was also the third center in the United States to perform over 1,000 heart transplants.

Using these partnerships, the company has found a way to increase the bioavailability of CBD up to 80 times. It disguises itself as water… sneaking right past your body’s defenses.

Not only that — it literally targets the drug to sites of inflammation.

With this technology, the company can develop economical CBD therapies for the $30.7 billion diastolic heart failure market for the first time in history.

Its CBD therapy is expected to enter Phase 1 clinical trials later this year, with a plan to enter Phase 2 in the second quarter of 2019.

I suggest that you read my full report on the company before those trial results come in.

This breakthrough could be a massive windfall.


Jimmy Mengel

follow basic @mengeled on Twitter

Jimmy is a managing editor for Outsider Club and the investment director of the personal finance advisory, The Crow's Nest, and cannabis stocks advisory, The Marijuana Manifesto. For more on Jimmy, check out his editor's page.

*Follow Outsider Club on Facebook and Twitter.

Heal Your Ailing Portfolio Body